These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Contraception today.
    Journal: Drug Merch; 1978 Jan; 59(1):24 ff. PubMed ID: 12309185.
    Abstract:
    Despite the massive amount of information available and the growing number of viable contraceptive methods, Canadians are failing to practice family planning. The number of abortions and unwanted pregnancies has increased. Too many women continue to become pregnant when they claim they do not want to be. One important contributing factor to this phenomenon is the dissemination of information, and this is 1 area where the pharmacist can assume more responsibility. The pharmacist - often among the 1st health professionals consulted about birth control - can provide an invaluable service by counselling on birth control. The OC continues to be the most frequently used contraceptive. Knowing that a number of drug interactions with OCs have been reported, the pharmacist can provide a valuable service by being aware of the potentials, and explaining them to the patient. The condom is an increasingly popular method of contraception, and the market is estimated at about $12 million a year to the pharmacy, with another $5 million in sales through government and agency distribution. The IUD market is difficult to estimate, because the product goes directly to the consumer. There have been several new products introduced in the last couple of years and several more are being prepared for the market. Progestasert, a progesterone uterine therapeutic system, has been on the market in Canada for about 1 year. A nonhormonal vaginal suppository is soon to be released in Canada. Expected on the U.S. market in 18 months is a collagen sponge diaphragm.
    [Abstract] [Full Text] [Related] [New Search]